AT III - Ruolo e Significato in Nefrologia e Nell'unità di Terapia Intensiva

Schmidt A. . Ueber den flüssigen Zustand des Blutes im Organismus. Zentralblatt für Physiologie 1890; 9: 257–9.

Heimburger N. . On the proteinase inhibitors of human plasma with especial reference to antithrombin. First international Symposium of tissue factors in the hae-mostasis of the coagulation-fibri-nolysis system. Firenze 1967; 353–62.

Abildgaard U. . Highly purifid antithrombin III with Heparin co-factor activity prepared by disc electrophoresis. Scand Clin Lab Invest 1968; 21: 89–91.

Petersen T.E. , Dudek-Wojcie-chowska G. , Sottrup-Jensen L. , Magnusson S. . Primary structure of antithrombin-III (heparin co-factor). Partial homology between alfa 1-antitrypsin and antithrombin-III. In: Collin D. , Wi-man B. , Verstraete M. , eds. The physiological inhibitors of coagulation and fibrinolysis. Elsevier-/North-Holland Biochemical Press 1979; 43–54.

Nordenman B. , Bjoerk I. . Binding of low-affinity and high-affinity heparin to antithrombin. Ultraviolet difference spectroscopy and circular dichroism studies. Biochemistry 1978; 17: 3339–44.

Collen D. , Schetz J. , de Cock F. , Holmer E. , Verstraete M. . Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration. Eur J Clin Invest 1977; 7: 27–35.

Abildgaard U. . Binding of thrombin to antithrombin III. Scand J Clin Lab Invest 1969; 24: 23–7.

Breddin H.K. , Kirchmaier C.M. , Witzke G. . Antithrombin III Replacement - versione italiana: le antiproteasi nella coagulazione -antitrombina III. I Quaderni de “II Ponte” 1989; 10.

Roka L. , Bleyl H. , Schmitz H. . Contribution of antithrombin, alpha-2-macroglobulin and fibrin to the inactivation of thrombin. In: Wenzel , eds. Antithrombin III: biochemistry, function, assay and clinical significance. Ermer, Homburg/Saar 1983; 47–8.

Abildgaard U. . A review of antithrombin III. In: Collen , eds. The physiological inhibitors of coagulation and fibrinolysis. Elsevier/North Holland Biomedical Press, Amsterdam 1979; 19–9.

Vinazzer H. , Woler M. . A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies. Thromb Res 1985; 40: 135–46.

Egeberg O. . Inherited antithrombin deficiency causing thrombophilia. Thrombos Diat-hes Haemorrh 1965; 13: 516–30.

Odegard O.R. , Abildgard U. . Antithrombin III: critical review of assay methods. Significance of variations in health and disease. Haemostasis 1978; 7: 127–34.

Scharrer I. . Untersuchungsprogramm bei Verdacht auf Throm-bophilie. Ellipse 1986; 9: 93–8.

Hellagren M. , Javelin L. , Haegnevik K. , Blombaeck M. . Antithrombin III in late pregnancy. Acta Obstet, Gynec Scand 1982; 61: 187–9.

Thaler E. . Pathogenese und klinische Bedeutung des erworbenen Antithrombin-III-Mangels in der inneren Medizin. Wien, Klin Wschr 1981; 93: 563–72.

Vogel G.E. , Bottermann P. , Clar-mann M.V. , Komm C.H. , Oberndorfer A. . Antithrombin III treatment in acute liver failure (Abstract). Thromb Haemostas 1981; 46: 373.

Egbring R. , Klingemann H.G. , Heimburger N. Antithrombin III substitution in acute hepatic failure due to CCl₄ intoxication. Thromb Haemostas 1981; 46: 373.

Brande S. , Arias J. , Hughes R. Antithrombin III infusion during fulminant hepatic failure (Abstract). Thrombos Haemostas 1981; 46: 369.

Castellani C. , De Gasperi T. . Terapia anticoagulante. In: Trattato Italiano di Dialisi. Ed. Wichtig Sez. 10, cap. 4.

Thaler E. , Balzer E. , Kopsa H. , Pin-ggera W.F. . Acquired antithrombin III deficiency in patients with glomerular proteinuria. Haemostasis 1978; 7: 257–72.

Kauffmann R.J. , Veltkamp J.J. , Van Tilburg N.H. , Van Es L.A. . Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med 1978; 65: 607–13.

Woo K.T. , Wei S.S. , Lee E.J.C. , Lau Y.K. , Lim C.H. . Effects of hemodialysis and peritoneal dialysis on antithrombin III and platelets. Nephron 1985; 40: 25.

Mori R. , Triolo L. , De Stefano V. , Giusti B.P. , De Sole P. , Leone G. . Plasma levels and loss of antithrombin III in chronic ambulatory peritoneal dialysis and nephrotic patients. Nephron 1988; 48: 213–6.

Motta M. , Rapisarda F. , Fatuzzo P. Comportamento dell'an-titrombina III e del fibrinopeptide A in pazienti uremici in trattamento emodialitico. In: Nefrologia, Dialisi, Trapianto 1988. Ed. Wichtig 1989; 421.

Fujiwara K. , Ogata I. , Ohta Y. Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III. Gut 1988; 29: 1103–8.

Bick R.L. , Dukes M.L. , Wilson W.L. , Fekete L.F. . Antithrombin III as a diagnostic aid in disseminated intravascular coagulation. Thromb Res 1977; 10: 721–9.

Thaler E. . Disseminierte intravaskuläre Gerinnung: Antithrombin III und Heparin. Folia hae-mat, Lpz 1977; 104: 740–50.

Bergmann H. , Blauhut B. , Necek S. , Kramar H. , Vinazzer H. . Heparin-prophylaxe der Ver-brauchskoagulopathie bei Shockpatienten: Abhängigkeit der Wirkung von der verfügbaren Antithrombin-III Aktivität. Anae-sthesist 1980; 29: 623–6.

Blauhut B. , Necek S. , Kramar H. , Vinazzer H. , Bergmann H. . Activity of antithrombin III and effect of heparin on coagulation in shock. Thromb Res 1980; 19: 775–82.

Jochum M. , Fritz H. , Duswald K.H. , Hiller E. . Plasma levels of human granulocytic elastase-alpha-1-proteinase inhibitor complex (E-alpha-1-PI) in patients with septicemia and acute leukemia. In: Goldbger Werner , eds. Selected topics in clinical enzymo-logy. de Gruyter, Berlin 1983; 85–100.

Vinazzer H. . Clinical use of antithrombin III concentrates. Vox Sang 1987; 53: 193–8.

Clemens R. . Virus safety of a pasteurized antithrombin III concentrate. Biol Clin Hematol 1987; 9(Suppl 1): 85–90.

Clemens R. , Weidmann E. , Merkle W. , Bock H.L. , Mauler R. , Hilfenhaus J. . Virus safety of a pasteurized antithrombin III concentrate. Preclinical and clinical data. Ar-zneim Forsch/Drug Res 1987; 37(II) 7: 759–62.

Gray S.P. , Billings I.A. . The determination of antithrombin III and its clinical application. JR Nav Med Serv 1979; 65/3: 147–64.

Kemkes-Matthes B. , Oehler G. , Matthes K.J. . Veränderungen von protein C, Faktor X und Antithrombin III beim Menschen während der Therapieumstellung von Heparin auf Phenprocoum Med Welt 1984; 35: 1479–81.

Lammle B. , Tran T.H. , Ritz R. , Duckert F. . Plasma prekallikrein, factor XII, antithrombin III, Cl-Inhibitor and alfa-2-Macroglo-bulin in critically ill patients with suspected disseminated intravascular coagulation (DIC) - Am J Clin Pathol 1984; 82: 396–404.

Mammen E.F. , Farag A.A. . The role of antithrombin III in DIC. Biol Clin Hematol 1987; 9(Suppl 1): 69–73.